Research programme: small molecule therapeutic - 4SC/Sanwa Kagaku Kenkyusho

Drug Profile

Research programme: small molecule therapeutic - 4SC/Sanwa Kagaku Kenkyusho

Latest Information Update: 09 Jul 2012

Price : $50

At a glance

  • Originator 4SC; Sanwa Kagaku Kenkyusho
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Diabetes mellitus

Most Recent Events

  • 30 Apr 2012 Preclinical development is in progress in Japan
  • 07 Dec 2006 4SC AG announced that the cooperation with Sanwa Kagaku Kenkyusho on the optimised target in the area of diabetes was completed in September 2006
  • 30 Sep 2006 No development reported - Early research for Diabetes mellitus in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top